A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

The decision came in response to a February lawsuit from a compounding industry group against the FDA's decision that there ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits ...

v. U.S. Food and Drug Administration (Case No. 4:24-CV-0953-P) and urges the court to issue a preliminary injunction blocking the FDA's February 2025 decision to remove Semaglutide injections from ...

Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date. (HealthDay News) — For patients with diabetes, semaglutide use is ...

LIKE MANY OTHER PROVIDERS, NP TO-GO OFFERED THEIR PATIENTS COPYCAT VERSIONS OF THE SEMAGLUTIDE FROM COMPOUNDING PHARMACIES, BUT THAT HAS COME TO A HALT AFTER THE FDA DECLARED THERE WAS NO LONGER A ...

He said, “Hey Joe, I’m getting these weird calls about semaglutide.” According to the specialist’s calculations, people were giving themselves 10 times the correct dose. But that didn’t ...

Ozempic copycats could come with hefty price tags as FDA declares end of semaglutide shortage Trump blames Zelensky for derailing London peace talks 20 Beautiful Baby Names From the 1940s That ...